Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing
June 1, 2020 - … the Janssen Pharmaceutical Companies of Johnson & Johnson, Novavax, and Vaxart that are currently underway. “Emergent’s … the Janssen Pharmaceutical Companies of Johnson & Johnson, Novavax, Inc., and Vaxart, Inc. to develop and manufacture … the Janssen Pharmaceutical Companies of Johnson & Johnson, Novavax, and Vaxart that are currently underway. “Emergent’s …
Emergent BioSolutions Reports Financial Results for First Quarter 2020
April 30, 2020 - … severe disease in humans. Signed a CDMO agreement with Novavax, Inc. to provide development services, drug substance … planned for late 2020. Signed a CDMO agreement with Novavax, Inc. to provide drug substance manufacturing of … severe disease in humans. Signed a CDMO agreement with Novavax, Inc. to provide development services, drug substance …
Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™
March 31, 2020 - … Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ 03/31/20 General CDMO … Inc. (NYSE:EBS) today announced an agreement with Novavax, Inc. (NASDAQ:NVAX) whereby Emergent will provide …
Emergent BioSolutions Signs Development and Manufacturing Agreement with Vaxart for their Experimental Oral Vaccine Candidate for Coronavirus Disease
March 18, 2020 - … drug substance for the company’s recently announced Novavax collaboration. The facility has the capacity to … drug substance for the company’s recently announced Novavax collaboration. The facility has the capacity to … drug substance for the company’s recently announced Novavax collaboration. The facility has the capacity to …
Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
March 10, 2020 - … Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus … Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus … announced today that it has entered into an agreement with Novavax, Inc. (NASDAQ:NVAX) whereby Emergent will collaborate …